PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.448
EU - Europa 9.822
AS - Asia 7.834
SA - Sud America 1.109
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
Totale 36.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.220
GB - Regno Unito 3.412
IT - Italia 2.816
CN - Cina 2.497
SG - Singapore 2.253
HK - Hong Kong 926
VN - Vietnam 869
BR - Brasile 838
SE - Svezia 707
DE - Germania 547
UA - Ucraina 487
FI - Finlandia 429
FR - Francia 408
RU - Federazione Russa 287
KR - Corea 278
TR - Turchia 273
NL - Olanda 213
BG - Bulgaria 170
IN - India 144
CA - Canada 123
ID - Indonesia 121
AR - Argentina 87
BD - Bangladesh 87
IE - Irlanda 75
MX - Messico 64
IQ - Iraq 50
EC - Ecuador 47
JP - Giappone 47
CO - Colombia 41
ZA - Sudafrica 41
ES - Italia 38
BE - Belgio 37
PK - Pakistan 36
AE - Emirati Arabi Uniti 35
CH - Svizzera 30
CL - Cile 30
PL - Polonia 29
AT - Austria 28
MA - Marocco 26
VE - Venezuela 25
IR - Iran 24
MY - Malesia 20
PH - Filippine 19
BY - Bielorussia 18
TN - Tunisia 18
NP - Nepal 16
UZ - Uzbekistan 16
DZ - Algeria 15
EU - Europa 13
PY - Paraguay 13
SA - Arabia Saudita 13
IL - Israele 12
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SN - Senegal 12
TH - Thailandia 12
EG - Egitto 11
KE - Kenya 10
NO - Norvegia 10
UY - Uruguay 10
AU - Australia 9
ET - Etiopia 9
JO - Giordania 9
LB - Libano 9
CR - Costa Rica 8
GE - Georgia 8
KZ - Kazakistan 8
PT - Portogallo 8
TW - Taiwan 7
AO - Angola 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
PA - Panama 6
RS - Serbia 6
YE - Yemen 6
AL - Albania 5
AZ - Azerbaigian 5
BH - Bahrain 5
GR - Grecia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
DK - Danimarca 4
HU - Ungheria 4
JM - Giamaica 4
NI - Nicaragua 4
PR - Porto Rico 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
EE - Estonia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 36.372
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Fairfield 1.719
Santa Clara 1.695
Ashburn 1.519
Woodbridge 1.392
Singapore 1.389
Jacksonville 1.005
Houston 969
Hefei 922
Hong Kong 904
Chandler 798
Dearborn 640
Wilmington 635
Seattle 593
Cambridge 573
Ann Arbor 561
Beijing 453
London 392
Nyköping 361
San Jose 284
Chicago 276
Helsinki 272
Ho Chi Minh City 272
Seoul 260
The Dalles 256
Los Angeles 255
Hanoi 216
Milan 214
Princeton 197
Modena 195
San Diego 175
Council Bluffs 173
Sofia 166
Eugene 162
Rome 150
Lauterbourg 148
Izmir 142
Buffalo 130
New York 124
Moscow 105
Dallas 103
Salt Lake City 87
Jakarta 78
Shanghai 71
Redwood City 69
Des Moines 68
Dublin 68
Turin 66
Naples 63
São Paulo 62
Bologna 60
Orem 57
Tokyo 41
Haiphong 39
Columbus 38
Tampa 38
Da Nang 37
Elk Grove Village 37
Nanjing 37
Rio de Janeiro 37
Genoa 36
Frankfurt am Main 35
Palermo 35
Brussels 34
Brooklyn 33
Dong Ket 33
Verona 33
Brescia 32
Florence 32
Ottawa 32
Phoenix 30
Bianco 29
Norwalk 29
Bremen 28
Paris 28
Boardman 27
Falkenstein 27
Guangzhou 27
Lancaster 27
Chennai 26
Falls Church 26
Munich 26
Toronto 26
Atlanta 25
Catania 24
Parma 22
Sterling 22
Tulare 21
Baghdad 20
Fremont 20
Jinan 20
Perugia 20
Philadelphia 20
Warsaw 20
Johannesburg 19
Mexico City 19
Miami 19
Guayaquil 17
Bari 16
Boston 16
Totale 25.551
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.120
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 774
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 402
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 395
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 358
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 343
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 338
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 336
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 331
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 325
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 306
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 306
A case-control study of visually evoked postural responses in childhood with primary headaches 303
Basal cutaneous pain threshold in headache patients 302
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 300
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 300
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 300
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 297
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 297
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 294
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 292
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 282
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 281
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 274
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 272
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 268
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 264
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 264
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 263
Long-term follow-up of patients treated for chronic headache with analgesic overuse 262
Effect of rofecoxib on nociception and the serotonin system in the rat brain 259
Headaches associated with chronic use of analgesics: A therapeutic approach 258
Italian guidelines for primary headaches: 2012 revised version. 258
Disposition of naproxen after oral administration during and between migraine attacks. 257
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 256
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 253
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 251
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 251
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 248
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 247
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 247
Analgesic abuse in chronic headache sufferers 246
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 246
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 245
Phenytoin-Treatment Of Rdeb Vegetans 243
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 241
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 241
An unusual case report on the possible role of Warfarin in migraine prophylaxis 240
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 239
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 237
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 236
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 235
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 233
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 230
Risk-benefit and cost-benefit ratio in headache treatment 230
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 228
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 227
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 226
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 225
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 224
Plasma glutathione level in chronic headache drug abuser patients 220
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 219
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 218
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 217
Nimodipine in otolaryngology: from past evidence to clinical perspectives 217
Relevance of analgesic abuse in the maintenance of chronic headaches 216
An emerging problem in clinical practice: how to treat chronic headache patients. 216
Chronic daily headache: how to manage it? 216
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 215
Triptans: the experience of a clinical pharmacologist in clinical practice. 213
Different characteristics of triptans 213
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 212
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 212
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 211
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 210
Analysis on the use of migraine preventative drugs in current clinical practice 209
Homocysteine levels and cardiovascular disease in migraine with aura 209
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 209
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 206
Tacrolimus pharmacokinetics in kidney transplant recipients. 205
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 204
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 204
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 204
High prevalence of patent foramen ovale in migraine with aura 203
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 202
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 202
Active reporting scheme: an example to evaluate specific adverse drug reactions. 201
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 200
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 199
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 198
Urinary neopterin in malignant lymphoma 198
Naloxone-reverisble antinociception by paracetamol in the rat. 197
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 197
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 195
PHARMACOKINETICS OF NAPROXEN AFTER ORAL-ADMINISTRATION DURING AND OUT OF MIGRAINE ATTACKS 194
Circadian variations of proopiocortin-related peptides in children with migraine. 193
Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study. 193
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 192
A CB1 agonist in the treatment of medication-overuse headache: a possible therapeutic strategy 192
The genetics of chronic headaches. 189
Totale 26.926
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021826 0 0 0 0 0 0 0 0 0 468 190 168
2021/20222.935 92 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/20269.553 716 540 1.207 1.289 1.331 822 1.203 664 1.084 697 0 0
Totale 36.515